G
Gilles Wandeler
Researcher at University of Bern
Publications - 180
Citations - 5530
Gilles Wandeler is an academic researcher from University of Bern. The author has contributed to research in topics: Medicine & Hepatitis B virus. The author has an hindex of 28, co-authored 139 publications receiving 4398 citations. Previous affiliations of Gilles Wandeler include Cheikh Anta Diop University.
Papers
More filters
Journal ArticleDOI
Rapid decline of anti-hepatitis C virus (HCV) antibodies following early treatment of incident HCV infections in HIV-infected men who have sex with men.
Karoline Aebi-Popp,Gilles Wandeler,Luisa Salazar-Vizcaya,Karin J. Metzner,Marcel Stöckle,Matthias Cavassini,Matthias Hoffmann,Alexander Lüthi,Franziska Marta Suter,Enos Bernasconi,Jan Fehr,Hansjakob Furrer,Andri Rauch +12 more
TL;DR: Treatment-induced HCV clearance was associated with a more pronounced decline in anti-HCV antibody levels and with higher rates of seroreversion compared with spontaneous clearance or untreated replicating HCV infection among HIV-infected MSM with incident HCV infections.
Journal ArticleDOI
Absence of Active Hepatitis C Virus Infection in Human Immunodeficiency Virus Clinics in Zambia and Mozambique.
Gilles Wandeler,Lloyd Mulenga,Michael A Hobbins,Candido Joao,Edford Sinkala,Jonas Hector,Musa Aly,Benjamin H. Chi,Matthias Egger,Michael J. Vinikoor +9 more
TL;DR: Among 1812 individuals infected with human immunodeficiency virus, no patient in rural Mozambique and 4 patients in urban Zambia were positive for anti-HCV antibodies, and none had confirmed HCV replication.
Journal ArticleDOI
Bridging the gap between HIV epidemiology and antiretroviral resistance evolution: Modelling the spread of resistance in South Africa.
Anthony Hauser,Katharina Kusejko,Leigh F. Johnson,Gilles Wandeler,Julien Riou,Fardo Goldstein,Matthias Egger,Matthias Egger,Roger D. Kouyos +8 more
TL;DR: By combining epidemiological data on HIV in South Africa with biological data on resistance evolution, the modelling approach identified key factors driving NNRTI resistance, highlighting the need of alternative first-line regimens.
Journal ArticleDOI
Chronic Hepatitis B Virus Coinfection Is Associated With Renal Impairment Among Zambian HIV-Infected Adults
Aggrey Mweemba,Arianna Zanolini,Lloyd Mulenga,Drew Emge,Drew Emge,Benjamin H. Chi,Gilles Wandeler,Michael J. Vinikoor,Michael J. Vinikoor +8 more
TL;DR: Among 6789 HIV-infected Zambian adults screened for hepatitis B virus (HBV) coinfection, estimated glomerular filtration rate (eGFR) was 50-90 mL/minute/1.73 m(2) in 17.6%, adjusted for age, sex, CD4(+) count, and World Health Organization disease stage.
Journal ArticleDOI
Brief Report: Switching From TDF to TAF in HIV/HBV-Coinfected Individuals With Renal Dysfunction-A Prospective Cohort Study.
Bernard Surial,Charles Béguelin,Jean-Philippe Chave,Marcel Stöckle,Noémie Boillat-Blanco,Thanh Doco-Lecompte,Enos Bernasconi,Jan Fehr,Huldrych F. Günthard,Patrick Schmid,Laura N Walti,Hansjakob Furrer,Andri Rauch,Gilles Wandeler +13 more
TL;DR: Switching from TDF to TAF among HIV/HBV-coinfected individuals with renal impairment led to improvements in eGFR, a decline in proteinuria, and to ALT normalization in those with elevated ALT levels one year after replacing TDF with TAF.